New pill shows promise for social anxiety in early trial

NCT ID NCT06693609

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a new oral drug called EMP-01 in 70 adults with social anxiety disorder. Participants received either EMP-01 or a placebo for a short time to see if the drug is safe and helps reduce anxiety in social situations. The main goal was to check for side effects, while also looking at whether symptoms improved over six weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MAC Clinical Research - Greater Manchester

    Manchester, Greater Manchester, M13 9NQ, United Kingdom

  • MAC Clinical Research - Lancashire

    Blackpool, Lancashire, FY2 0JH, United Kingdom

  • MAC Clinical Research - Merseyside

    Liverpool, Merseyside, L34 1BH, United Kingdom

  • MAC Clinical Research - South Staffordshire

    Bridgetown, Cannock, Staffordshire, S75 3DL, United Kingdom

  • MAC Clinical Research - South Yorkshire

    Tankersley, South Yorkshire, S75 3DL, United Kingdom

  • MAC Clinical Research - Teesside

    Thornaby, Stockton-on-Tees, TS17 6EW, United Kingdom

  • MAC Clinical Research Centre, West Yorkshire

    Leeds, LS10 1DU, United Kingdom